Protocol Category
Immune Support
Thymic and antimicrobial peptide protocols for immune modulation and resilience.
Beginner
Immune Optimization & Infection Resistance Protocol
A protocol for healthy adults seeking to optimize baseline immune function, enhance resistance to recurrent infections, and slow the immune senescence that accelerates after age 40 — combining thymic restoration, antimicrobial peptides, and longevity-oriented immune signaling.
Long COVID & Post-Viral Syndrome Recovery Protocol
A multi-target peptide protocol for individuals with Long COVID (PASC) or post-viral syndrome. Addresses the converging pathologies: persistent immune dysregulation, mitochondrial dysfunction, neuroinflammation, autonomic nervous system disruption, and vascular endothelial injury that sustain symptoms beyond acute infection.
Intermediate
Alopecia Areata & Autoimmune Hair Loss Protocol
A targeted protocol for alopecia areata (autoimmune hair loss) combining immune-modulating peptides with hair follicle growth stimulants to address both the inflammatory root cause and promote follicular re-activation.
Ankylosing Spondylitis & Axial Spondyloarthropathy Protocol
A peptide-based adjunct protocol for ankylosing spondylitis (AS) and axial spondyloarthropathy (axSpA), targeting the IL-17A/TNF-driven inflammation, spinal ligament ossification cascade, and associated gut microbiome dysbiosis.
Autoimmune & Systemic Inflammation Protocol
A comprehensive protocol targeting autoimmune dysregulation and chronic systemic inflammation using peptides that modulate immune checkpoints, reduce cytokine storms, and restore peripheral tolerance.
Celiac Disease & Gluten-Related Disorders Protocol
An adjunctive protocol for individuals with celiac disease or non-celiac gluten sensitivity, targeting the intestinal barrier dysfunction, autoimmune mucosal damage, and nutritional malabsorption that persist despite gluten-free diet adherence.
Chronic Fatigue & Post-Viral Recovery Protocol
Targeted protocol for chronic fatigue syndrome, post-viral fatigue (including long COVID), and ME/CFS. Addresses mitochondrial dysfunction, immune dysregulation, and neuroinflammation simultaneously.
Chronic Lyme Disease & Post-Lyme Syndrome Protocol
A comprehensive immune-restoration and symptom-management protocol for chronic Lyme disease and post-treatment Lyme disease syndrome (PTLDS), addressing persistent inflammation, neuropathic pain, and immune dysregulation.
Endometriosis & Pelvic Pain Management Protocol
A peptide-based adjunct protocol for endometriosis addressing the chronic pelvic inflammatory environment, adhesion formation, neuro-sensitization underlying dysmenorrhea, and the immune dysregulation driving retrograde endometrial implantation.
Immune Defense & Longevity Protocol
A comprehensive immune optimization stack combining a clinically-approved immune modulator, thymus restoration, antimicrobial defense, and anti-inflammatory peptides to build robust immune resilience, especially valuable for chronic infections, post-viral recovery, and immune aging.
Immune Restoration & Anti-Inflammatory Protocol
A comprehensive immune system restoration and chronic inflammation reduction protocol targeting multiple immune pathways. Addresses T-cell function, NK cell activity, regulatory immune balance, and systemic inflammatory cytokine reduction.
Inflammatory Bowel Disease (Crohn's & Ulcerative Colitis)
A gut-targeted peptide protocol for Crohn's disease and ulcerative colitis, addressing mucosal barrier restoration, Th17/Treg immune dysregulation, microbiome normalization, and reduction of inflammatory cytokine cascade in remission maintenance.
Long COVID & Post-Viral Fatigue Recovery Protocol
A comprehensive immune restoration and mitochondrial recovery protocol for Long COVID and post-viral fatigue syndrome, addressing persistent viral immune dysregulation, autonomic dysfunction, and cellular energy failure.
Psoriasis & Inflammatory Skin Conditions Protocol
A peptide protocol for individuals with psoriasis, psoriatic arthritis, or chronic inflammatory skin conditions. Targets the dysregulated Th17/IL-23 axis, keratinocyte hyperproliferation, skin barrier dysfunction, and gut-skin axis immune dysregulation that drive psoriatic disease.
Psoriasis & Inflammatory Skin Disease Protocol
A peptide protocol combining systemic anti-inflammatory, immunomodulatory, and barrier-repair compounds to manage psoriasis plaques, reduce flare frequency, and restore skin barrier integrity.
Psoriasis & Psoriatic Arthritis Management Protocol
A peptide-based adjunct protocol for psoriasis and psoriatic arthritis, targeting the IL-23/Th17 axis, skin barrier dysfunction, and inflammatory arthropathy that characterize psoriatic disease.
Rheumatoid Arthritis & Autoimmune Joint Disease Protocol
A targeted protocol for rheumatoid arthritis and autoimmune joint conditions combining immunomodulation, synovial inflammation reduction, cartilage protection, and joint tissue repair.
Rheumatoid Arthritis Joint & Immune Protocol
A peptide-based adjunct protocol for rheumatoid arthritis (RA) targeting synovial inflammation, joint destruction prevention, immune dysregulation, and the systemic cardiovascular and metabolic comorbidities of active RA.
Skin Cancer Prevention & UV Defense Protocol
A protective protocol for high UV-exposure individuals combining systemic melanin upregulation, DNA repair enhancement, immunosurveillance optimization, and skin barrier protection to reduce UV-induced carcinogenesis risk.
Advanced
Ankylosing Spondylitis & Axial Spondyloarthropathy Protocol
An adjunctive protocol for individuals with ankylosing spondylitis and axial spondyloarthropathy, targeting the IL-17/IL-23-driven enthesitis, progressive syndesmophyte formation, and the TNF-driven inflammatory cascade that cause irreversible spinal fusion.
Ankylosing Spondylitis & Axial Spondyloarthropathy Protocol
Anti-inflammatory and joint-protective peptide protocol for ankylosing spondylitis targeting spinal inflammation, syndesmophyte prevention, and preservation of spinal mobility.
Crohn's Disease & IBD Management Protocol
Peptide-based protocol targeting intestinal inflammation, barrier repair, and mucosal immune regulation for Crohn's disease and ulcerative colitis management.
Endometriosis & Pelvic Pain Management Protocol
Multi-mechanism peptide protocol for endometriosis addressing peritoneal inflammation, lesion-driven angiogenesis, central sensitization pain, and immune dysregulation underlying the disease.
HIV Support & Immune Restoration Protocol
A supportive protocol for people living with HIV on stable antiretroviral therapy (ART), addressing residual immune activation, HIV-associated neurocognitive disorders (HAND), peripheral neuropathy, lean mass wasting, and accelerated aging phenotypes.
Hashimoto's Thyroiditis & Autoimmune Thyroid Protocol
Immunomodulatory peptide protocol targeting the autoimmune destruction of thyroid tissue in Hashimoto's, aimed at reducing TPO/TG antibody titers, restoring immune tolerance, and protecting residual thyroid function.
Hashimoto's Thyroiditis & Autoimmune Thyroid Protocol
An adjunctive protocol for individuals with Hashimoto's thyroiditis targeting the Th1/Th17 dysregulation, molecular mimicry mechanisms, and intestinal barrier dysfunction that drive thyroid autoantibody production and progressive thyroid destruction.
Hepatitis C & Viral Hepatitis Support Protocol
A supportive protocol for patients with chronic viral hepatitis (HCV, HBV) combining thymic immune restoration, direct antiviral peptides, and hepatoprotective compounds to enhance viral clearance, reduce hepatic fibrosis, and improve treatment outcomes alongside standard antiviral therapy.
Inflammatory Bowel Disease (Crohn's) Management Protocol
An adjunctive protocol targeting the intestinal barrier dysfunction, mucosal inflammation, and immune dysregulation central to Crohn's disease and severe ulcerative colitis, designed to complement but not replace conventional IBD therapy.
Lupus (SLE) Immune Modulation Protocol
A peptide-based adjunct protocol for systemic lupus erythematosus (SLE), targeting the type I interferon excess, Th17/Treg imbalance, and autoantibody-driven tissue inflammation underlying lupus flares.
Lupus (SLE) Immune Regulation Protocol
Targeted immunomodulatory peptide protocol for systemic lupus erythematosus (SLE) aimed at restoring immune tolerance, reducing autoantibody production, and protecting target organs.
Mold Illness & CIRS Recovery Protocol
A multi-target protocol for Chronic Inflammatory Response Syndrome (CIRS) from mold biotoxin exposure, addressing immune dysregulation, neuroinflammation, VIP deficiency, and mucosal healing.
Multiple Sclerosis Immune Modulation Protocol
A peptide protocol for individuals with relapsing-remitting or progressive multiple sclerosis seeking complementary immune modulation and neuroprotection. Targets the dysregulated Th1/Th17 autoimmune response, demyelination, neuroinflammation, and axonal loss that drive MS progression.
Multiple Sclerosis Neuroprotection & Remyelination Protocol
A neuroprotective and pro-remyelination protocol for multiple sclerosis targeting neuroinflammation suppression, oligodendrocyte progenitor activation, axonal protection, and immune tolerance restoration.
Multiple Sclerosis Neuroprotective Support Protocol
A multi-target adjunct protocol for multiple sclerosis addressing T-cell mediated autoimmunity, demyelination, neuropathic pain, mitochondrial failure in neurons, and gastrointestinal health.
Post-Chemotherapy Recovery & Immune Reconstitution
A comprehensive peptide recovery protocol for cancer survivors completing chemotherapy, targeting immune system reconstitution, GI mucosal repair, peripheral neuropathy recovery, fatigue reduction, and restoration of hematopoietic function.
Post-Chemotherapy Recovery & Immune Reconstitution Protocol
A comprehensive recovery protocol for cancer survivors completing chemotherapy, addressing the profound immune depletion, peripheral neuropathy, mitochondrial toxicity, gut mucosal damage, and persistent fatigue that characterize post-chemotherapy syndrome.
Post-Organ Transplant Support Protocol
A supportive peptide protocol for organ transplant recipients to reduce rejection risk, support tissue integration, minimize immunosuppressant toxicity, and promote organ function recovery. All interventions must be reviewed with the transplant team, as this is a medically complex population.
Post-Transplant Longevity & Infection Resistance Protocol
An immunomodulatory and anti-aging adjunct protocol for organ transplant recipients aiming to preserve graft function, combat the accelerated aging driven by immunosuppression, and reduce infection risk.
Rheumatoid Arthritis & Autoimmune Joint Disease Management Protocol
An adjunctive protocol for individuals with rheumatoid arthritis or other autoimmune joint conditions, targeting the T-cell dysregulation, inflammatory signaling cascades, and joint tissue destruction characteristic of autoimmune arthropathies.
Scleroderma & Systemic Sclerosis Protocol
A multi-target protocol for scleroderma (systemic sclerosis) addressing the three core pathological processes: autoimmune activation, vasculopathy, and progressive fibrosis.
Sepsis Recovery & Systemic Inflammation Resolution Protocol
A targeted protocol for post-sepsis syndrome recovery, addressing the persistent immunosuppression, organ damage, and hyperinflammatory sequelae that follow septic episodes.
Systemic Lupus Erythematosus (SLE) Management Protocol
An adjunctive protocol for individuals with SLE targeting the pathological T-cell and B-cell dysregulation, complement overactivation, end-organ inflammation, and accelerated aging processes that characterize this complex systemic autoimmune disease.
Thymic Immune Bioregulator Stack
Comprehensive thymic restoration stack using short-chain bioregulatory peptides from the thymus gland to reverse immunosenescence, restore T-cell diversity, and rebuild adaptive immunity in aging individuals.
Thymic Immune Restoration Protocol
Full thymic axis restoration protocol for immunosenescence reversal, T-cell diversity expansion, and enhanced immune surveillance. Combines thymic peptides, antimicrobial defense, and NAD+ immune energetics.
Type 1 Diabetes Immune Modulation & Beta-Cell Preservation Protocol
A protocol targeting the autoimmune mechanisms of Type 1 diabetes to preserve remaining beta-cell mass, reduce islet inflammation, restore immune tolerance to beta-cell antigens, and improve glycemic control.
Type 1 Diabetes Immune Modulation & Beta-Cell Support
A peptide-based adjunct protocol for Type 1 diabetes and LADA (Latent Autoimmune Diabetes in Adults) targeting beta-cell preservation, autoimmune tolerance restoration, and reduction of the accelerating autoimmune destruction that characterizes newly-diagnosed and early T1D.